Literature DB >> 20729345

Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages.

Zhongping Xiao1, Wenjing Zhao, Bo Yang, Zhenqing Zhang, Huashi Guan, Robert J Linhardt.   

Abstract

Porcine intestinal mucosa heparin was partially depolymerized by recombinant heparinase 1 (heparin lyase 1, originating from Flavobacterium heparinum and expressed in Escherichia coli) and then fractionated, leading to the isolation of 22 homogeneous oligosaccharides with sizes ranging from disaccharide to hexadecasaccharide. The purity of these oligosaccharides was determined by gel electrophoresis, strong anion exchange and reversed-phase ion-pairing high-performance liquid chromatography. The molecular mass of oligosaccharides was determined using electrospray ionization-mass spectrometry and their structures were elucidated using one- and two-dimensional nuclear magnetic resonance spectroscopy at 600 MHz. Five of the characterized oligosaccharides represent new compounds. The most prominent oligosaccharide comprises the common repeating unit of heparin, ΔUA2S-[-GlcNS6S-IdoA2S-](n)-GlcNS6S, where ΔUA is 4-deoxy-α-l-threo-hex-4-eno-pyranosyluronic acid, GlcN is 2-deoxy-2-amino-d-glucopyranose, IdoA is l-idopyranosyluronic acid, S is sulfate and n = 0-7. A second prominent heparin oligosaccharide motif corresponds to ΔUA2S-[GlcNS6S-IdoA2S](n)-GlcNS6S-IdoA-GlcNAc6S-GlcA-GlcNS3S6S (where n = 0-5 and GlcA is d-glucopyranosyluronic acid), a fragment of the antithrombin III binding site in heparin. The prominence of this second set of oligosaccharides and the absence of intact antithrombin III binding sites suggest that the -GlcNS3S6S-IdoA2S- linkage is particularly susceptible to heparinase 1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729345      PMCID: PMC2998982          DOI: 10.1093/glycob/cwq123

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  24 in total

1.  Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.

Authors:  Marco Guerrini; Daniela Beccati; Zachary Shriver; Annamaria Naggi; Karthik Viswanathan; Antonella Bisio; Ishan Capila; Jonathan C Lansing; Sara Guglieri; Blair Fraser; Ali Al-Hakim; Nur Sibel Gunay; Zhenqing Zhang; Luke Robinson; Lucinda Buhse; Moheb Nasr; Janet Woodcock; Robert Langer; Ganesh Venkataraman; Robert J Linhardt; Benito Casu; Giangiacomo Torri; Ram Sasisekharan
Journal:  Nat Biotechnol       Date:  2008-04-23       Impact factor: 54.908

2.  Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I.

Authors:  S Ernst; A J Rhomberg; K Biemann; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

3.  Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin.

Authors:  Z Shriver; M Sundaram; G Venkataraman; J Fareed; R Linhardt; K Biemann; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

4.  Structural studies on the tri- and tetrasaccharides isolated from porcine intestinal heparin and characterization of heparinase/heparitinases using them as substrates.

Authors:  S Yamada; K Sakamoto; H Tsuda; K Yoshida; K Sugahara; K H Khoo; H R Morris; A Dell
Journal:  Glycobiology       Date:  1994-02       Impact factor: 4.313

5.  Purification and characterization of heparin lyases from Flavobacterium heparinum.

Authors:  D L Lohse; R J Linhardt
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

6.  Substrate specificity of the heparin lyases from Flavobacterium heparinum.

Authors:  U R Desai; H M Wang; R J Linhardt
Journal:  Arch Biochem Biophys       Date:  1993-11-01       Impact factor: 4.013

7.  Quantification of heparan sulfate disaccharides using ion-pairing reversed-phase microflow high-performance liquid chromatography with electrospray ionization trap mass spectrometry.

Authors:  Zhenqing Zhang; Jin Xie; Haiying Liu; Jian Liu; Robert J Linhardt
Journal:  Anal Chem       Date:  2009-06-01       Impact factor: 6.986

8.  Tandem MS can distinguish hyaluronic acid from N-acetylheparosan.

Authors:  Zhenqing Zhang; Jin Xie; Jian Liu; Robert J Linhardt
Journal:  J Am Soc Mass Spectrom       Date:  2007-10-30       Impact factor: 3.109

9.  Action pattern of polysaccharide lyases on glycosaminoglycans.

Authors:  K A Jandik; K Gu; R J Linhardt
Journal:  Glycobiology       Date:  1994-06       Impact factor: 4.313

10.  Preparation and structural characterization of large heparin-derived oligosaccharides.

Authors:  A Pervin; C Gallo; K A Jandik; X J Han; R J Linhardt
Journal:  Glycobiology       Date:  1995-02       Impact factor: 4.313

View more
  21 in total

1.  Structure of decorin binding protein B from Borrelia burgdorferi and its interactions with glycosaminoglycans.

Authors:  Wei Feng; Xu Wang
Journal:  Biochim Biophys Acta       Date:  2015-08-11

2.  Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.

Authors:  Anna Alekseeva; Benito Casu; Giuseppe Cassinelli; Marco Guerrini; Giangiacomo Torri; Annamaria Naggi
Journal:  Anal Bioanal Chem       Date:  2013-11-20       Impact factor: 4.142

3.  Asparagine 405 of heparin lyase II prevents the cleavage of glycosidic linkages proximate to a 3-O-sulfoglucosamine residue.

Authors:  Wenjing Zhao; Marie-Line Garron; Bo Yang; Zhongping Xiao; Jeffrey D Esko; Miroslaw Cygler; Robert J Linhardt
Journal:  FEBS Lett       Date:  2011-07-06       Impact factor: 4.124

4.  Structure and activity of a new low-molecular-weight heparin produced by enzymatic ultrafiltration.

Authors:  Li Fu; Fuming Zhang; Guoyun Li; Akihiro Onishi; Ujjwal Bhaskar; Peilong Sun; Robert J Linhardt
Journal:  J Pharm Sci       Date:  2014-03-14       Impact factor: 3.534

5.  Synthesis of 3-O-Sulfated Disaccharide and Tetrasaccharide Standards for Compositional Analysis of Heparan Sulfate.

Authors:  Vijay Manohar Dhurandhare; Vijayakanth Pagadala; Andreia Ferreira; Louis De Muynck; Jian Liu
Journal:  Biochemistry       Date:  2019-10-23       Impact factor: 3.162

6.  Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides.

Authors:  Wenjing Zhao; Scott A McCallum; Zhongping Xiao; Fuming Zhang; Robert J Linhardt
Journal:  Biosci Rep       Date:  2012-02       Impact factor: 3.840

7.  Impact of autoclave sterilization on the activity and structure of formulated heparin.

Authors:  Julie M Beaudet; Amanda Weyers; Kemal Solakyildirim; Bo Yang; Majde Takieddin; Shaker Mousa; Fuming Zhang; Robert J Linhardt
Journal:  J Pharm Sci       Date:  2011-03-17       Impact factor: 3.534

8.  Negative electron transfer dissociation Fourier transform mass spectrometry of glycosaminoglycan carbohydrates.

Authors:  Franklin E Leach; Jeremy J Wolff; Zhongping Xiao; Melissa Ly; Tatiana N Laremore; Sailaja Arungundram; Kanar Al-Mafraji; Andre Venot; Geert-Jan Boons; Robert J Linhardt; I Jonathan Amster
Journal:  Eur J Mass Spectrom (Chichester)       Date:  2011       Impact factor: 1.067

9.  Structurally informative tandem mass spectrometry of highly sulfated natural and chemoenzymatically synthesized heparin and heparan sulfate glycosaminoglycans.

Authors:  Muchena J Kailemia; Lingyun Li; Yongmei Xu; Jian Liu; Robert J Linhardt; I Jonathan Amster
Journal:  Mol Cell Proteomics       Date:  2013-02-21       Impact factor: 5.911

10.  Profiling glycol-split heparins by high-performance liquid chromatography/mass spectrometry analysis of their heparinase-generated oligosaccharides.

Authors:  Anna Alekseeva; Benito Casu; Giangiacomo Torri; Sabrina Pierro; Annamaria Naggi
Journal:  Anal Biochem       Date:  2012-11-29       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.